BioAge Labs, Inc. BIOA
NASDAQ · United States · Health Technology
$6.61-0.20 (-2.94%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.58 | -0.61 | +4.5% | $2.45M | +63.7% | +0.6%$11.20→$11.27 |
| Q1 2026 | 2026-05-08 | -0.52 | -0.63 | +17.5% | — | — | +1.9%$17.82→$18.16 |
| Q4 2025 | 2026-03-24 | -0.72 | -0.67 | -7.5% | — | — | -11.9%$18.63→$16.41 |
| Q3 2025 | 2025-11-06 | -0.56 | -0.67 | +16.4% | — | — | -3.2%$7.50→$7.26 |
| Q4 2024 | 2025-03-20 | -1.75 | -0.66 | -165.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.